Your browser doesn't support javascript.
loading
Immune responses and clinical outcomes following the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in advanced breast cancer patients receiving targeted therapies: a prospective study.
Nelli, Fabrizio; Fabbri, Agnese; Botticelli, Andrea; Giannarelli, Diana; Marrucci, Eleonora; Fiore, Cristina; Virtuoso, Antonella; Berrios, Julio Rodrigo Giron; Scagnoli, Simone; Pisegna, Simona; Cirillo, Alessio; Panichi, Valentina; Massari, Annalisa; Silvestri, Maria Assunta; Ruggeri, Enzo Maria.
Afiliación
  • Nelli F; Department of Oncology and Hematology, Medical Oncology and Breast Unit, Central Hospital of Belcolle, Viterbo, Italy.
  • Fabbri A; Department of Oncology and Hematology, Medical Oncology and Breast Unit, Central Hospital of Belcolle, Viterbo, Italy.
  • Botticelli A; Department of Radiological, Oncological and Pathological Science, Sapienza University of Rome, Rome, Italy.
  • Giannarelli D; Biostatistics Unit, Scientific Directorate, Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
  • Marrucci E; Department of Oncology and Hematology, Medical Oncology and Breast Unit, Central Hospital of Belcolle, Viterbo, Italy.
  • Fiore C; Department of Oncology and Hematology, Medical Oncology and Breast Unit, Central Hospital of Belcolle, Viterbo, Italy.
  • Virtuoso A; Department of Oncology and Hematology, Medical Oncology and Breast Unit, Central Hospital of Belcolle, Viterbo, Italy.
  • Berrios JRG; Department of Oncology and Hematology, Medical Oncology and Breast Unit, Central Hospital of Belcolle, Viterbo, Italy.
  • Scagnoli S; Department of Radiological, Oncological and Pathological Science, Sapienza University of Rome, Rome, Italy.
  • Pisegna S; Department of Radiological, Oncological and Pathological Science, Sapienza University of Rome, Rome, Italy.
  • Cirillo A; Department of Radiological, Oncological and Pathological Science, Sapienza University of Rome, Rome, Italy.
  • Panichi V; Department of Oncology and Hematology, Cytofluorimetry Unit, Central Hospital of Belcolle, Viterbo, Italy.
  • Massari A; Department of Oncology and Hematology, Pathology Unit, Central Hospital of Belcolle, Viterbo, Italy.
  • Silvestri MA; Department of Oncology and Hematology, Microbiology and Virology Unit, Central Hospital of Belcolle, Viterbo, Italy.
  • Ruggeri EM; Department of Oncology and Hematology, Medical Oncology and Breast Unit, Central Hospital of Belcolle, Viterbo, Italy.
Front Oncol ; 13: 1280416, 2023.
Article en En | MEDLINE | ID: mdl-38023235
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Suiza